PHL-SODIUM POLYSTYRENE SULFONATE POWDER Poudre

Country: Կանադա

language: ֆրանսերեն

source: Health Canada

active_ingredient:

Polystyrène sulfonate de sodium

MAH:

PHARMEL INC

ATC_code:

V03AE01

INN:

POLYSTYRENE SULPHONATE

dosage:

94.3MG

pharmaceutical_form:

Poudre

composition:

Polystyrène sulfonate de sodium 94.3MG

administration_route:

Orale

units_in_package:

454G

prescription_type:

Prescription

therapeutic_area:

POTASSIUM-REMOVING AGENTS

leaflet_short:

Numéro de groupe d'ingrédients actifs (GIA) :0108701003; AHFS:

authorization_status:

ANNULÉ APRÈS COMMERCIALISATION

authorization_date:

2014-02-10